Can the WiseTech Global (ASX:WTC) share price climb higher from here?

The WiseTech Global Ltd (ASX:WTC) share price has been a strong performer over the last month. Can its shares continue to rise?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The WiseTech Global Ltd (ASX: WTC) share price has been a strong performer in recent weeks.

Since this time in March, the logistics solutions provider's shares have risen by a solid 12.5%.

This compares favourably to a 4.5% gain by the S&P/ASX 200 Index (ASX: XJO) over the same period.

Woman in mustard yellow blouse on laptop holds both hands out to either side with graphic illustration of question marks above them

Image source: Getty Images

Why is the WiseTech Global share price on form?

The catalyst for the strong gain by the WiseTech Global share price appears to have been a broker note out of Macquarie Group Ltd (ASX: MQG) last month.

That note reveals that the broker upgraded its shares to an outperform rating with a $33.00 price target.

Macquarie made the move on the belief that the worst of the pandemic is now behind the company and upgraded its earnings forecasts to reflect this.

With the WiseTech Global share price fetching $30.75 today, this implies potential upside of approximately 7.5% over the next 12 months.

What are other brokers saying?

This morning, Bell Potter gave its verdict on the WiseTech Global share price.

According to the note, the broker has held firm with its hold rating and lifted its price target to $31.50.

Bell Potter commented: "We believe there is upside risk to WiseTech's FY21 revenue and EBITDA guidance for two key reasons: 1. Global trade volumes continue to rebound strongly post the impacts of the US-China trade war in 1HFY20 and COVID in 2HFY20; and 2. The AUD/USD exchange rate has averaged 0.77 so far this half whereas the guidance assumes an average of 0.79 in 2HFY21."

"We also note the continued lack of any M&A activity this half which supports a strong EBITDA margin in 2HFY21 similar or better than the EBITDA margin in 1HFY21," it added.

In addition, the broker believes that the resumption of the share sell down by its CEO is actually a positive.

The broker explained: "We also believe the flagged recommencement of Richard White's sell down implies the company is at least on track to achieve its guidance as we doubt the CEO would be selling if the result was not going to be good."

However, due to its valuation, it isn't enough for the broker to upgrade its rating to buy just yet.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of WiseTech Global. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a miner holds his thumb up as he holds a device in his other hand.
Resources Shares

Experts name 3 ASX mining shares to buy after March sell-off

Investors took profits amid fears the fuel crisis could impact miners' production and earnings.

Read more »

A woman holds her finger to the side of her face and looks upwards as she thinks about something.
Broker Notes

4 ASX shares at 52-week lows: Buy, hold, or sell?

Here's what the experts think.

Read more »